$GL

Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL)

Globe Life Inc. (NYSE:GL) reported Q2 2026 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. Premium revenue rose 7% (life +3%, health +16%). The company repurchased $175 million of shares and guided full-year net operating EPS growth of 8.5%.

Original reporting
Published Jul 23, 2026, 8:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 5:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL) — source image
Decision brief

The 30-second read

$GLBullishMed
01

Why it matters

Traders can update expectations for full-year growth and EPS trajectory based on management’s stated ranges, and reassess buyback-driven support given the annual repurchase target.

02

Market read

New full-year guidance ranges and the annual share repurchase target are the primary tradable takeaways from the transcript.

03

What to watch

Agent count at American Income Life declined year over year despite sequential improvement; recruitment and retention execution could be a swing factor for second-half sales growth.

Relevance 8/10Novelty 7/10Timing: post-market transcript of Q2 2026 earnings call, with full-year guidance and buyback outlook

Background

The article is a full transcript of Globe Life’s Q2 2026 earnings call, covering operating performance, distribution trends, investment income, AI cost initiatives, and capital return.

Company-level read

Ticker impact

$GLBullishMedium confidence
Context

Globe Life reported Q2 2026 results and guided full-year premium growth, normalized EPS growth, and $670 to $700 million buybacks.

Expected impact

Likely supportive for GL shares if investors view the EPS and buyback guidance as credible versus expectations.

Evidence & confidence

The transcript includes multiple forward-looking datapoints (full-year premium growth range, normalized EPS growth 9% to 10%, and annual repurchases $670 to $700 million) plus Q2 beats on net income per share and net operating income per share.

Market effects

Reinforces demand and pricing strength in Medicare supplement and life/health lines, with AI as a cost and sales-efficiency lever for insurers.

No specific regional market catalyst beyond US insurance operations.

Limited, as the disclosures are company-specific and US-focused insurance fundamentals.

Counterpoint

Health underwriting margin was down year over year, and AI-driven expense benefits are described as longer-term, which could temper enthusiasm.

Key entities

  • Globe Life Inc.

    US life and health insurer reporting Q2 2026 results and providing full-year guidance and buyback outlook.

  • American Income Life

    Distribution channel discussed for agent count and life sales trends.

  • Liberty National

    Distribution channel discussed for life premium growth and underwriting margin.

Related articles

$GLMedAI 8/10

Globe Life Boosts EPS Outlook Following Strong Q2 Earnings

Globe Life Inc. reported Q2 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. The insurer cited underwriting strength and excess investment returns and raised full-year guidance to 2026 net operating EPS of $15.55-$15.95 and share repurchases of $670M-$700M.

$GLMed

Why Globe Life (GL) Shares Are Sliding Today

Globe Life (NYSE: GL) shares fell about 7% after its Q2 results met Wall Street estimates but did not provide upside. Revenue rose 6.7% to about $1.6B and net premiums earned were about $1.30B. GAAP EPS was $3.65 vs $3.64 expected. The stock closed at $170.96.

$GLMedAI 8/10

Globe Life Q2 Earnings Call Highlights

Globe Life (NYSE:GL) reported Q2 health premium revenue up 16% to $437M and health underwriting margin up 1% to $99M, though the margin fell to about 23%. Life policy obligations improved. Management raised 2026 net operating EPS guidance to $15.55 to $15.95 and increased buybacks. The company repurchased ~1.1M shares for $175M in Q2.

$GLMedAI 8/10

Why is Globe Life stock sliding today? By Investing.com

Globe Life shares fell 8.1% after its Q2 2026 results. Net operating income was $3.61 per diluted share versus $3.67 consensus, while revenue was $1.60B versus $1.59B. Full-year 2026 EPS guidance was raised to $15.55-$15.95 but the midpoint ($15.75) stayed below $15.65 consensus, alongside insider net selling and a risk-off market.

$GLMed

GLOBE LIFE INC. (GL): Results of Operations and Financial Condition

GLOBE LIFE INC. (GL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2fy2026earningsrelease.htm EX-99.1 Document GLOBE LIFE INC. REPORTS Second Quarter 2026 Results McKinney, TX, July 22, 2026 —Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with

$GLMedAI 8/10

GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS

Globe Life Inc. (NYSE: GL) reported Q2 2026 results for the quarter ended June 30, 2026. Net income was $3.65 per diluted share versus $3.05 a year ago. Full-year 2026 earnings guidance was raised to $15.55 to $15.95. Premium revenue rose 7% and the company repurchased 1.1 million shares for $175 million.